Mesothelioma, Solitary Fibrous Tumor of the Pleura
Conditions
Brief summary
The purpose of this study is to determine the response rate and overall survival in patients that have been diagnosed with mesothelioma and will undergo chemotherapy, surgery and intensity modified radiation therapy (IMRT) as part of their standard of care.
Detailed description
The investigators will consent patients that have been diagnosed with mesothelioma and will undergo chemotherapy followed by surgery and then IMRT as their standard of care. The investigators will collect data from past and future medical records as well as data regarding their health status for their lifetime by reviewing life status, treatment status and CT scans.
Interventions
None listed
Sponsors
Mayo Clinic
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Subject provides informed consent * Subject is \>18 years of age * Subject is deemed competent for making medical decisions * Subject is scheduled to undergo chemotherapy followed by surgery and then IMRT * Subject is a surgical candidate * A negative pregnancy test is required in women of child-bearing potential, as standard of care.
Exclusion criteria
•Subject is \<18 years old.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Overall Survival (OS) | 2 years | OS is defined as the length of time from study enrollment to death by any cause. Survival status of patients will be monitored every 6 months |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Progression free survival (PFS) as evidenced by CT scan review | 2 years | PFS is defined as the length of time from study enrollment to the time of disease progression. |
Countries
United States
Outcome results
None listed